A phase I study of the oral administration of irinotecan in combination with the potent P-glycoprotein (P-gp) inhibitor HM30181A. Phase I study of DFP-11207, a novel oral 5-FU with enhanced PK and ...

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. COVID-19 infection is associated with a significant increase in the corrected QT interval (QTc) in ...

Evaluation of utility of pharmacokinetic studies in phase I combination trials. ApoStream, a novel device for antibody-independent capture of circulating cancercells (CCCs) from blood of patients with ...

Long QT syndrome is a leading cause of sudden death in young persons, with a prevalence exceeding 1 in 2000. It is characterized by prolongation of the QT interval, aberrant T-wave morphologic ...

(HealthDay News) — Use of a computerized clinical decision support system (CDSS) may reduce the risk of prolonged QT c interval in hospitalized patients at risk for torsades de pointes, according to ...

Researchers have been using artificial intelligence (AI) to develop a mobile device that can identify certain patients at risk of sudden cardiac death. Researchers from Mayo Clinic and AliveCor Inc.

Please provide your email address to receive an email when new articles are posted on . Treatment with hydroxychloroquine does not impact corrected QT length among patients with rheumatoid arthritis ...

As more consumer-facing devices add features to measure the heart’s electrical activity, companies are looking for new ways to turn this data into valuable health information. AliveCor, a startup that ...